The application of mesenchymal stromal cells (MSCs) and their derivative exosome in skin wound healing: a comprehensive review
Применение мезенхимальных стромальных клеток (МСК) и производных от них экзосом для заживления кожных ран: всесторонний обзор
2022-01-24
SCID: 54.1/sj6mpa3t
Discuss with AI
MSC-derived exosomesangiogenesiscell-free therapymesenchymal stromal cellsskin wound healing
Figures from the paper
Abstract (AI)
Recently, mesenchymal stromal cells (MSCs) and also their exosome has become a game-changing tool in the context of tissue engineering and regenerative medicine. MSCs due to their competencies to establish skin cells, such as fibroblast and keratinocyte, and also their unique attribute to suppress inflammation in wound site has attracted increasing attention among scholars. In addition, MSC's other capabilities to induce angiogenesis as a result of secretion of pro-angiogenic factors accompanied with marked anti-fibrotic activities, which mainly mediated by the releases matrix metalloproteinase (MMPs), make them a rational and effective strategy to accelerate wound healing with a small scar. Since the chief healing properties of the MSCs depend on their paracrine effects, it appears that MSCs-derived exosomes also can be an alternative option to support wound healing and skin regeneration as an innovative cell-free approach. Such exosomes convey functional cargos (e.g., growth factor, cytokine, miRNA, etc.) from MSCs to target cells, thereby affecting the recipient skin cells' biological events, such as migration, proliferation, and also secretion of ECM components (e.g., collagen). The main superiorities of exosome therapy over parental MSCs are the diminished risk of tumor formation and also lower immunogenicity. Herein, we deliver an overview of recent in vivo reports rendering the therapeutic benefits of the MSCs-based therapies to ease skin wound healing, and so improving quality of life among patients suffering from such conditions.
Key Findings
1
Compared with parental MSC therapy, exosomes may reduce tumor-formation risk and immunogenicity; the review summarizes recent in vivo evidence supporting these therapies.
2
Exosomal cargo influences recipient-cell migration, proliferation, and extracellular-matrix production, including collagen secretion.
3
MSC-derived exosomes provide a cell-free regenerative approach by transferring growth factors, cytokines, and miRNAs to target skin cells.
4
MSCs accelerate wound repair through pro-angiogenic factor secretion and anti-fibrotic activity mediated primarily by matrix metalloproteinases.
5
Mesenchymal stromal cells support skin wound healing by promoting fibroblast and keratinocyte formation while suppressing local inflammation.
Research Object
mesenchymal stromal cells (MSCs) and MSC-derived exosomes in skin wound healing
Research Subject
the therapeutic mechanisms and benefits of MSC- and exosome-based therapies for accelerating skin wound healing and regeneration while reducing inflammation, fibrosis, and scarring
Publication Details
Publication Date
2022-01-24
Journal
Publisher
ISSN
Cited by
383
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest